T GF-3, is a pleiotropic cytokine whose primary functions include stimulation of wound healing (1) and suppression of multiple immune cell types (2) (3) (4) . TGF-31 can be released by a number of cell types including B cells, T cells, macrophages, and platelets (1) (2) (3) (5) (6) (7) (8) . TGF-~x was recently shown to stimulate IgA production by LPS-activated murine B cells in vitro by inducing an IgA class switch (9) (10) (11) (12) (13) . Similar results were recently obtained using human B cells (14) (15) (16) .
LPS stimulates large amounts of IgM and induces class switching to IgG3 and IgG2b (17, 18) . We observed that the ratio of secreted IgG2b to that of IgG3, IgG1, or IgM upon LPS activation varied dramatically depending upon the strain of mouse from which the B cells were derived. Thus, B cells derived from BALB/c mice secreted relatively low amounts of IgG2b, upon LPS stimulation, relative to cells obtained from DBA/2 mice. Since no cytokine has been described which regulates IgG2b secretion in a positive manner, we used LPS-activated B cells from BALB/c mice to screen for cytokines that selectively stimulate the expression of this Ig isotype. We now show that TGF-31 selectively induces IgG2b secretion by LPS-, but not anti-IgD-dextran-, activated B cells. This data supports our previous contention that the nature of the B cell activator plays a pivotal role in determining cytokine-directed Ig isotype production (19, 20) and further indicates, in combination with other data, that three cytokines can selectively regulate two of the six non-IgM, non-IgD murine Ig isotypes in a positive manner: II:4:IgG1 (21) and IgE (22) ; IFN-y: IgG2a (23) and IgG3 (20) ; and TGF-31: IgG2b and IgA (9, 10) .
Materials and Methods
Mice. Female BALB/c and DBA/2 mice were obtained from the National Cancer Institute (Frederick, MD) and were used at 7-9 wk of age.
Medium. RPMI 1640 (Biofluids, Inc., Rockville, MD) supplemented with 10% fetal bovine serum (GIBCO BILL, Gaithersburg, MD), t-glutamine (2 mM), 2-ME (0.05 mM), penicillin (50 /~g/ml), and streptomycin (50/,g/ml) were used for culturing cells.
Preparation and Culture of B Cells. Enriched, T-depleted populations of small splenic B cells were obtained as described (24) . Functional assays were carried out in 96-well flat-bottomed plates (Costar Corp., Cambridge, MA). Cultured cells were incubated at 37~ in a humidified atmosphere containing 6% CO2.
Reagents (27) were purified from ascites. B cells from BALB/c and DBA/2 mice express IgH of the a-allotype and hence do not bind MB86 (27) .
Electronic Cell Sorting. Highly purified (>99%) membrane (m)IgM § -B cells were obtained by electronic cell sorting of B calls stained with PE-anti-IgM plus FITC-anti-IgG2b using a FACStar Plus | (Becton Dickinson & Co., Mountain View, CA) as described (28) .
Quantitation ofSecretedlg Isotypex Ig isotype concentrations were measured by an ELISA assay as described (24) . Briefly, Immulon 2, %-well flat-bottomed ELISA phtes (Dynatech Laboratories, Inc., Alexandria, VA) were used, and a fluorescent product was generated by cleavage of 4-methyl umbilliferyl phosphate (Sigma Immunochemicals, St. Louis, MO) with specifically bound alkaline phosphatase-conjugated antibodies. Ig isotype concentrations were determined by extrapolation from standard curves.
Quantitation of lg Isotype-secreting Cells. Ig isotype-secreting cells were quantitated by an ELISPOT assay (29) . Briefly, flat-bottomed Immulon I microtiter plates (Dynatech Laboratories, Inc.), were coated with goat anti-mouse Ig and blocked with 1% BSA in PBS. Serial dilutions of single cell suspensions, starting with 2 x 105 cells/well, were incubated on anti-Ig-coated plates for 7 h at 37~ in a 5% COs in air incubator. The cells were washed away with PBS/0.05% Tween 20, and the plates were overlaid for 2 h with phosphatase-conjugated isotype-specific antibodies to mouse Ig (Southern Biotechnology Associates). The antibodies produced by individual B cells which bound to the plate were visualized by addition of a 5-bromo-3-chloroindolyl phosphate solution (Sigma Immunochemicals).
Detection of Steady-state Levels of Germline C.9/3 and C.T2b RNA. Steady-state levels of germline C.~/3 RNA were measured by Northern blot analysis. 20/xg of total RNA, extracted from cultured cells, was separated, by dectrophoresis, in a formaldehydecontaining 1% agarose gel and blotted onto a nylon membrane 1 Abbreviations used in this paper: et~-dex, dextran-conjugated anti-lgD antibodies; m, membrane.
according to standard protocols. The blot was then hybridized with a eDNA specific for I3'3 (30) that was labeled with 32p-deoxycytidine by the random hexamer method, and was subsequently exposed to X-ray film. In addition, 20 #g of total RNA, extracted from the same cell populations that were utilized to measure germline "y3 transcripts, was hybridized to a 32p-labeled probe specific for germline 3~2b transcripts to assay for steady-state levels of germline C.3,2b RNA by the $1 nuclease protection assay as described (31).
Results and Discussion
In initial experiments we observed that the relative amounts of IgG2b, IgG3, IgG1, and IgM secreted in response to LPS stimulation in vitro differed between B cells from BALB/c vs. DBA/2 mice. In four experiments BALB/c-derived B cells secreted 6-10-fold less IgG2b than DBA/2-derived B cells, whereas their secretion of IgG3, IgG1, or IgM was either comparable or somewhat higher (Table 1) . Thus, BALB/ c-derived B cells were used to search for cytokines which selectively stimulated IgG2b secretion in response to LPS.
We observed that purified bovine TGF-fll stimulated a dose-dependent increase in IgG2b and IgA secretion by LPSactivated B cells in vitro (Fig. 1) . Maximal IgG2b and IgA secretion typically occurred between 0.3-1.0 ng/ml, a dose range similar to that reported by others for maximal IgA enhancement (9, 10). Optimal stimulation of IgG2b was observed when TGF-fll was added 24 h after addition of LPS and when cells were cultured at relatively high cell densities (2.5-10 x 10S/ml). The TGF-fll-induced enhancement in IgG2b secretion was observed in six separate experiments. In contrast, similar concentrations of TGF-B1 failed to stimulate, and variably inhibited, LPS-induced IgM, IgG3, and IgG1 production (Fig. 1) . Addition of TGF-B1 >1.0 ng/ml typically led to a decrease in all Ig isotypes, and this was associated with a marked reduction in viable cell yields relative to that observed with LPS activation alone. This was consistent with the antiproliferative effect of TGF-fll described by others (2, 3) . Similar results were obtained using purified porcine TGF-fll (data not shown). Although it has been reported that the addition of either I1-5 or II.-2 can selectively enhance TGF-fll-mediated induction of IgA secretion by LPS-activated B cells (10), we observed no selective induction of IgG2b secretion by either I1.-2 or Ib5 on LPS plus TGF-fll-activated cells (data not shown).
Addition of increasing amounts of a neutralizing monoclonal anti-TGF-fll antibody to B cell cultures stimulated with LPS and 1.0 ng/ml of TGF-fll resulted in a selective reduction in IgG2b secretion, whereas an isotype-matched control mAb had no significant effect (Table 2 ). This indicated that the IgG2b-enhancing activity was due to TGF-fl~ and not some contaminant in the TGF-fl~ preparation.
To determine whether the TGF-fll-mediated increase in IgG2b secretion was due to an increase in the number of IgG2b-secreting cells, or the amount of IgG2b secreted per cell, the number of Ig isotype-secreting cells generated in response to LPS and TGF-fll was determined using an ELISPOT assay (Fig. 2 ). Cells were analyzed 4. BALB/c-derived B cells were cultured for 24 h with LPS (40/zg/ml) at 5 x 10 s cells/ml in a total of 100/zl of medium upon which varying concentrations of TGF-fll were added in 100 #1 of medium to achieve the final concentrations illustrated in the figure. Culture supernatants were removed 6 d after initiation of culture and Ig isotype concentrations were measured by an ELISA. All groups were established in triplicate. BALB/c-derived B cells were stimulated for 24 h at 5 x 10S/ml in the presence of LPS (40/~g/ml). 24 h later T.GF-fll (final concentration 1.0 ng/ml) with or without anti-TGF-fl (10/zg/ml final concentration) or control mAb (MB86) (10/zg/ml final concentration) were added to culture in an equal volume. Culture supernatants were removed 6 d after initiation of culture for measurement of Ig isotype concentrations by ELISA.
declined at 1.0 ng/ml of TGF-~I by 5.5-, 14.8-, and 4.2-fold, respectively. Further addition of 1.0 ng/ml of TGF-B1 to LPS-activated cultures led to a reduction of 2.5-fold in viable cell yields. Thus, TGF-B1 increased IgG2b secretion by LPSactivated B cells primarily by increasing the number of cells secreting Ig of that isotype. To determine whether TGF-~/1 acted directly on B cells and stimulated class switching, highly purified (>99%) mlgM + mlgG2b-cells were isolated by electronic cell sorting and stimulated with LPS in the presence or absence of TGF-~I (Table 3) . TGF-~/1 selectively induced IgG2b secretion by LPS-activated mlgM+mlgG2b -cells indicating its direct action on the B cell and suggesting that it promoted a class switch to IgG2b.
An increase in the steady state levels of germline C. RNA specific for a particular C, gene typically precedes class switching to the expression of that gene (32, 33) . To further assess whether TGF-~I acted as a switch factor for IgG2b we determined whether it selectively induced germline C.~/2b RNA in LPS-activated B cells (Fig. 3) . TGF-B1 induced a 2-2.5-fold increase in the steady-state levels of germline C,'y2b RNA in LPS-activated B cells while concomitantly reducing, by 2-2.5-fold, the levels of germline C.'y3. The enhancement in steady-state levels of germline C,3'2b RNA by TGF-~I was 2-3-fold lower than the associated induction of IgG2b secretion. However, steady-state levels of germline C.'y2b RNA may underestimate the degree of transcriptional activation of the C.'y2b gene, the relationship between germline C. gene transcription and Ig class switching may not be a linear one, and/or other parameters in the response of B cells to TGF-~I may further regulate IgG2b synthesis.
Additional experiments demonstrated that a neutralizing anti-TGF-B1 antibody specifically and selectively reduced IgG2b secretion by LPS-activated DBA/2-derived B cells (Fig.  4) . Thus, it appears that endogenous TGF-~I accounted for the ability of DBA/2-derived B cells to synthesize relatively high amounts of IgG2b in response to LPS.
We previously determined that cross-linkage of the antigen receptor of small B cells by dextran-linked anti-IgD (cz6-dex) provided a powerful costimulus for cytokine-directed Ig isotype production (34) . Yet, o~6-dex was unable to costimulate an IgE response in the presence of even high concentrations of IL-4 (19) . We further observed a distinct lack of IgG2b secretion by ol&dex-activated B cells in the presence of cytokines contained within either activated CD4 § Thl or Th2 supernatants (19) . To determine whether TGF-B1 could ) and either anti-TGF-B1 mAb (11911.16.8) (10 #g/m1) to neutralize any endogenous TGF-/31, or an isotype-matched control mAb (MB86) (10 #g/ml) at 5 x 10S/ml in 25 ml of medium upon which medium alone or TGF-Bt (2.0 ng/ml), respectively, were added in 25 ml of medium, Cells were harvested 3 d after initiation of culture and total KNA was extracted for quantitation of steady-state levels of germline C.3"2b by the $1 nuclease protection assay or C.3'3 by Northern blot analysis. Ethidium bromide (EtBr) staining of RNA is included to show essentially equal quantities of RNA used from each group. Small splenic B cells were stained with FITC-anti-IgG2b plus PE-anti-IgM, mlgM+mlgG2b -cells were isolated by electronic cell sorting to >99% purity and stimulated with LPS (40 #g/ml) at 5 x 10 s cells/ml. 24 h later, an equal volume of medium with or without 1.0 ng/ml of TGF-31 was added. Culture supernatant was removed 6 d after initiation of culture with LPS, and IgM, IgG3, and IgG2b concentrations were measured by ELISA. induce IgG2b secretion by oe~-dex-activated B cells, we added varying amounts of TGF-31 to B cells induced to secrete Ig by c~&dex plus IL-5 (Fig. 5) . Although TGF-3, dearly acted on c~r plus IL-5-activated cells by virtue of its ability to inhibit IgM secretion in a dose-dependent fashion, it failed to stimulate detectable secretion of IgG2b. This further supported our model that the nature of the B cell activator plays a pivotal role in cytokine-directed Ig isotype production (19, 20) .
Thus, our data strongly suggests that TGF-flt stimulates IgG2b class switching by LPS-activated B cells in that TGF-31: (a) selectively stimulates the secretion of only IgG2b and IgA; (b) selectively increases the number of IgG2b-secreting cells; (c) acts on mlgM+mlg2b -cells to induce IgG2b secretion; and (d) increases the steady-state levels of germline C,3,2b RNA.
In light of our findings, it is of interest that an earlier study demonstrating the ability of TGF-~l to selectively stimulate IgA production found that TGF-B1 inhibited the secretion of IgM, IgG3, IgG1, and IgG2a, but did not inhibit the synthesis of IgG2b (10) . The failure to see a significant induction in IgG2b secretion may have reflected, in part, the relatively high levels of IgG2b secretion induced by LPS alone, perhaps due to endogenous TGF-B1. In this regard, we observed that although DBA/2-derived B cells made substantial amounts of IgG2b in response to LPS alone (secondary to endogenous TGF-/81), they secreted only modest amounts of IgA (comparable with that seen utilizing B cells from BALB/c mice). This could in part reflect the need for somewhat higher concentrations of TGF-B1 for optimal IgA vs. IgG2b secretion as is suggested in Fig. 1 .
Another group, which earlier reported the ability of joint fluids from rheumatoid arthritis patients to selectively stimulate IgG2b-secreting murine B cells when cultured by LPS in vitro (35) , found no affect of TGF-~I on IgG2b induction (36) . Although the reason for this is presently unclear, the failure of human TGF-~I at 1 and 2 ng/ml, to diminish the number of IgM-, IgGl-, and IgG3-secreting cells over that seen with LPS alone calls into question the activity of their TGF-31 preparation. Nevertheless, the IgG2b-inducing activity in joint fluids was ascribed to a 50-60 kD molecule, suggesting that a factor in addition to TGF-B1 may also be capable of enhancing the secretion of IgG2b.
We are currently investigating the basis for the strain-related differences in magnitude of in vitro LPS-induced IgG2b secretory responses. Preliminary work from our laboratory suggests that LPS-activated DBA/2-derived B cells secrete TGF-/31. Whether the differences in IgG2b secretion among B cells derived from other strains of mice reflect differences in the amount of endogenous TGF-31 produced, or whether these B cells have differing sensitivities to TGF-31 action, needs to be determined. It is interesting that we recently observed that BALB/c mice immunized with LPS produced lower levels of serum, LPS-specific IgG2b, relative to IgM and IgG3, when compared with similarly immunized DBA/2 mice (Snapper, C. M., unpublished observations). Whether TGF-31 plays a physiologic role in the in vivo IgG2b response to LPS immunization is being investigated. Finally, it will be interesting to determine whether the constitutive, selective expression of germline C,3'2b transcripts and C.3'2b rearrangement typically seen in murine Abelson virus-transformed pre-B cell lines (33) is also due to endogenous production of TGF-3I.
